Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The 17th biennial International Symposium on Acute Leukemias took place in Munich, Germany, from February 24– 27, 2019. This meeting brought together researchers and clinicians to discuss the most recent findings in the understanding and treatment of AML, ALL and APL.
Dive into the latest updates and expert insights, including the frontier of precision medicine, immunotherapies such as triplebodies and CiTEs, epigenetic heterogeneity and targeting, clonal interference and preleukemic clones, MRD quantification and application, and the unmet need of hematology patients in the ICU.
ISAL 2019
The 17th biennial International Symposium on Acute Leukemias took place in Munich, Germany, from February 24– 27, 2019. This meeting brought together researchers and clinicians to discuss the most recent findings in the understanding and treatment of AML, ALL and APL.
Dive into the latest updates and expert insights, including the frontier of precision medicine, immunotherapies such as triplebodies and CiTEs, epigenetic heterogeneity and targeting, clonal interference and preleukemic clones, MRD quantification and application, and the unmet need of hematology patients in the ICU.
